- Same Thing
- Side Effects
- What Is
- Drug Interactions
Are Trikafta and Kalydeco the Same Thing?
Trikafta is used to treat used to treat cystic fibrosis in patients aged 12 years and older who have at least one F508del mutation in the CFTR gene. If the patient's genotype is unknown, an FDA-cleared CF mutation test should be used to confirm the presence of at least one F508del mutation.
Kalydeco is used to treat a rare form of cystic fibrosis (CF) in patients ages 6 years and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene.
Side effects of Trikafta and Kalydeco that are similar include headache, upper respiratory tract infection, stomach/abdominal pain, diarrhea, rash, and cold symptoms (stuffy nose, sneezing, sore throat, post-nasal drip).
Side effects of Trikafta that are different from Kalydeco include influenza, increased alanine aminotransferase, increased blood creatine phosphokinase, increased aspartate aminotransferase, and increased blood bilirubin.
Both Trikafta and Kalydeco may interact with antibiotics and antifungals.
Trikafta may also interact with rifampin, rifabutin, seizure medications, St. John's wort, glimepiride and glipizide, digoxin, cyclosporine, everolimus, sirolimus, tacrolimus, statins, glyburide, nateglinide, and repaglinide.
What Are Possible Side Effects of Trikafta?
Common side effects of Trikafta include:
What Are Possible Side Effects of Kalydeco?
Common side effects of Kalydeco include:
- upper respiratory tract infection,
- stomach pain,
- joint or muscle pain, or
- cold symptoms (stuffy nose, sneezing, sore throat).
Serious side effects of Kalydeco include:
- liver problems,
- severe stomach pain,
- chest pain,
- shortness of breath,
- loss of appetite,
- dark urine,
- clay-colored stools,
- jaundice (yellowing of the skin or eyes), or
- low blood sugar (headache, hunger, weakness, sweating, confusion, irritability, dizziness, fast heart rate, or feeling jittery).
What Is Trikafta?
Trikafta (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets) is a combination of ivacaftor, a CFTR potentiator, tezacaftor, and elexacaftor used to treat cystic fibrosis (CF) in patients aged 12 years and older who have at least one F508del mutation in the CFTR gene. If the patient’s genotype is unknown, an FDA-cleared CF mutation test should be used to confirm the presence of at least one F508del mutation.
What Is Kalydeco?
Kalydeco (ivacaftor) film-coated tablets are a CFTR potentiator indicated for the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene.
What Drugs Interact With Trikafta?
Trikafta may interact with other medicines such as:
- seizure medications,
- St. John’s wort,
- azole antifungals,
- macrolide antibiotics,
- glimepiride and glipizide,
- nateglinide, and
Tell your doctor all medications and supplements you use.
What Drugs Interact With Kalydeco?
Kalydeco may interact with:
- grapefruit juice,
- Seville oranges,
- St. John's wort,
- heart or blood pressure medications,
- hepatitis C medications,
- HIV/AIDS medications,
- medicines used to prevent organ transplant rejection,
- medicines to treat narcolepsy, or
- seizure medications
Tell your doctor all medications and supplements you use.
How Should Trikafta be Taken?
The morning dose of Trikafta for adults and pediatric patients aged 12 years and older is two elexacaftor 100 mg, tezacaftor 50 mg and ivacaftor 75 mg tablets. The evening dose of Trikafta for adults and pediatric patients aged 12 years and older is one ivacaftor 150 mg tablet. The morning and evening doses of Trikafta should be taken approximately 12 hours apart with fat-containing food.
How Should Kalydeco be Taken?
In adults and pediatric patients age 6 years and older, one 150 mg Kalydeco tablet should be given orally every 12 hours with fat-containing food. Dosage of Kalydeco should be reduced when co-administered with moderate and severe hepatic impairment.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Vertex Pharmaceuticals Incorporated. Kalydeco Product Information.